世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Bolus Injectors Market Growth 2025-2031

Global Bolus Injectors Market Growth 2025-2031


The global Bolus Injectors market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Bolus ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
LP Information
LPインフォメーション
2025年1月16日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
お問合わせください 93 英語

 

Summary

The global Bolus Injectors market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Bolus Injectors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bolus Injectors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bolus Injectors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bolus Injectors players cover Unilife Corporation, West Pharmaceuticals, BD Medical, Dickinson and Company, Sensile Medical AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Bolus Injectors Industry Forecast” looks at past sales and reviews total world Bolus Injectors sales in 2024, providing a comprehensive analysis by region and market sector of projected Bolus Injectors sales for 2025 through 2031. With Bolus Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bolus Injectors industry.
This Insight Report provides a comprehensive analysis of the global Bolus Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bolus Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bolus Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bolus Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bolus Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of Bolus Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Electronic
Mechanical
Hydrogel
Hydraulic
Segmentation by Application:
Cancer
Autoimmune Dieases
Genetic Disorders
Blood Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Unilife Corporation
West Pharmaceuticals
BD Medical
Dickinson and Company
Sensile Medical AG
SteadyMed Therapeutics
Ratio Inc.
Valeritas Inc.
Roche
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bolus Injectors market?
What factors are driving Bolus Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bolus Injectors market opportunities vary by end market size?
How does Bolus Injectors break out by Type, by Application?


ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bolus Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bolus Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bolus Injectors by Country/Region, 2020, 2024 & 2031
2.2 Bolus Injectors Segment by Type
2.2.1 Electronic
2.2.2 Mechanical
2.2.3 Hydrogel
2.2.4 Hydraulic
2.3 Bolus Injectors Sales by Type
2.3.1 Global Bolus Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global Bolus Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bolus Injectors Sale Price by Type (2020-2025)
2.4 Bolus Injectors Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Dieases
2.4.3 Genetic Disorders
2.4.4 Blood Disorders
2.4.5 Others
2.5 Bolus Injectors Sales by Application
2.5.1 Global Bolus Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global Bolus Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bolus Injectors Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bolus Injectors Breakdown Data by Company
3.1.1 Global Bolus Injectors Annual Sales by Company (2020-2025)
3.1.2 Global Bolus Injectors Sales Market Share by Company (2020-2025)
3.2 Global Bolus Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global Bolus Injectors Revenue by Company (2020-2025)
3.2.2 Global Bolus Injectors Revenue Market Share by Company (2020-2025)
3.3 Global Bolus Injectors Sale Price by Company
3.4 Key Manufacturers Bolus Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bolus Injectors Product Location Distribution
3.4.2 Players Bolus Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bolus Injectors by Geographic Region
4.1 World Historic Bolus Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global Bolus Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bolus Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bolus Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global Bolus Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bolus Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bolus Injectors Sales Growth
4.4 APAC Bolus Injectors Sales Growth
4.5 Europe Bolus Injectors Sales Growth
4.6 Middle East & Africa Bolus Injectors Sales Growth
5 Americas
5.1 Americas Bolus Injectors Sales by Country
5.1.1 Americas Bolus Injectors Sales by Country (2020-2025)
5.1.2 Americas Bolus Injectors Revenue by Country (2020-2025)
5.2 Americas Bolus Injectors Sales by Type (2020-2025)
5.3 Americas Bolus Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bolus Injectors Sales by Region
6.1.1 APAC Bolus Injectors Sales by Region (2020-2025)
6.1.2 APAC Bolus Injectors Revenue by Region (2020-2025)
6.2 APAC Bolus Injectors Sales by Type (2020-2025)
6.3 APAC Bolus Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bolus Injectors by Country
7.1.1 Europe Bolus Injectors Sales by Country (2020-2025)
7.1.2 Europe Bolus Injectors Revenue by Country (2020-2025)
7.2 Europe Bolus Injectors Sales by Type (2020-2025)
7.3 Europe Bolus Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bolus Injectors by Country
8.1.1 Middle East & Africa Bolus Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bolus Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa Bolus Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa Bolus Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bolus Injectors
10.3 Manufacturing Process Analysis of Bolus Injectors
10.4 Industry Chain Structure of Bolus Injectors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bolus Injectors Distributors
11.3 Bolus Injectors Customer
12 World Forecast Review for Bolus Injectors by Geographic Region
12.1 Global Bolus Injectors Market Size Forecast by Region
12.1.1 Global Bolus Injectors Forecast by Region (2026-2031)
12.1.2 Global Bolus Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bolus Injectors Forecast by Type (2026-2031)
12.7 Global Bolus Injectors Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Unilife Corporation
13.1.1 Unilife Corporation Company Information
13.1.2 Unilife Corporation Bolus Injectors Product Portfolios and Specifications
13.1.3 Unilife Corporation Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Unilife Corporation Main Business Overview
13.1.5 Unilife Corporation Latest Developments
13.2 West Pharmaceuticals
13.2.1 West Pharmaceuticals Company Information
13.2.2 West Pharmaceuticals Bolus Injectors Product Portfolios and Specifications
13.2.3 West Pharmaceuticals Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 West Pharmaceuticals Main Business Overview
13.2.5 West Pharmaceuticals Latest Developments
13.3 BD Medical
13.3.1 BD Medical Company Information
13.3.2 BD Medical Bolus Injectors Product Portfolios and Specifications
13.3.3 BD Medical Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BD Medical Main Business Overview
13.3.5 BD Medical Latest Developments
13.4 Dickinson and Company
13.4.1 Dickinson and Company Company Information
13.4.2 Dickinson and Company Bolus Injectors Product Portfolios and Specifications
13.4.3 Dickinson and Company Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dickinson and Company Main Business Overview
13.4.5 Dickinson and Company Latest Developments
13.5 Sensile Medical AG
13.5.1 Sensile Medical AG Company Information
13.5.2 Sensile Medical AG Bolus Injectors Product Portfolios and Specifications
13.5.3 Sensile Medical AG Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sensile Medical AG Main Business Overview
13.5.5 Sensile Medical AG Latest Developments
13.6 SteadyMed Therapeutics
13.6.1 SteadyMed Therapeutics Company Information
13.6.2 SteadyMed Therapeutics Bolus Injectors Product Portfolios and Specifications
13.6.3 SteadyMed Therapeutics Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SteadyMed Therapeutics Main Business Overview
13.6.5 SteadyMed Therapeutics Latest Developments
13.7 Ratio Inc.
13.7.1 Ratio Inc. Company Information
13.7.2 Ratio Inc. Bolus Injectors Product Portfolios and Specifications
13.7.3 Ratio Inc. Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ratio Inc. Main Business Overview
13.7.5 Ratio Inc. Latest Developments
13.8 Valeritas Inc.
13.8.1 Valeritas Inc. Company Information
13.8.2 Valeritas Inc. Bolus Injectors Product Portfolios and Specifications
13.8.3 Valeritas Inc. Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Valeritas Inc. Main Business Overview
13.8.5 Valeritas Inc. Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Bolus Injectors Product Portfolios and Specifications
13.9.3 Roche Bolus Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/01/20 10:26

157.08 円

162.01 円

194.17 円

ページTOPに戻る